231 related articles for article (PubMed ID: 35454904)
1. Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution.
Tzoras E; Zerdes I; Tsiknakis N; Manikis GC; Mezheyeuski A; Bergh J; Matikas A; Foukakis T
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454904
[TBL] [Abstract][Full Text] [Related]
2. The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy.
Kuczkiewicz-Siemion O; Sokół K; Puton B; Borkowska A; Szumera-Ciećkiewicz A
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954496
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
Isaacs J; Anders C; McArthur H; Force J
Curr Treat Options Oncol; 2021 Mar; 22(5):38. PubMed ID: 33743085
[TBL] [Abstract][Full Text] [Related]
4. Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence.
Tien TZ; Lee JNLW; Lim JCT; Chen XY; Thike AA; Tan PH; Yeong JPS
Histopathology; 2021 Aug; 79(2):139-159. PubMed ID: 33400265
[TBL] [Abstract][Full Text] [Related]
5. A Review of Artificial Intelligence in Precise Assessment of Programmed Cell Death-ligand 1 and Tumor-infiltrating Lymphocytes in Non-Small Cell Lung Cancer.
Wu J; Lin D
Adv Anat Pathol; 2021 Nov; 28(6):439-445. PubMed ID: 34623343
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.
Boisson A; Noël G; Saiselet M; Rodrigues-Vitória J; Thomas N; Fontsa ML; Sofronii D; Naveaux C; Duvillier H; Craciun L; Larsimont D; Awada A; Detours V; Willard-Gallo K; Garaud S
Front Mol Biosci; 2021; 8():673042. PubMed ID: 34621785
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.
Mori H; Bolen J; Schuetter L; Massion P; Hoyt CC; VandenBerg S; Esserman L; Borowsky AD; Campbell MJ
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):417-432. PubMed ID: 33590360
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
9. Multiplex Tissue Imaging: Spatial Revelations in the Tumor Microenvironment.
van Dam S; Baars MJD; Vercoulen Y
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804939
[TBL] [Abstract][Full Text] [Related]
10. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.
Gorris MAJ; Halilovic A; Rabold K; van Duffelen A; Wickramasinghe IN; Verweij D; Wortel IMN; Textor JC; de Vries IJM; Figdor CG
J Immunol; 2018 Jan; 200(1):347-354. PubMed ID: 29141863
[TBL] [Abstract][Full Text] [Related]
11. The spatial distribution of immune cell subpopulations in hepatocellular carcinoma.
Wang PC; Hu ZQ; Zhou SL; Yu SY; Mao L; Su S; Li J; Ren N; Huang XW
Cancer Sci; 2022 Feb; 113(2):423-431. PubMed ID: 34779545
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed immunohistochemistry for immune cell phenotyping, quantification and spatial distribution in situ.
Vasaturo A; Galon J
Methods Enzymol; 2020; 635():51-66. PubMed ID: 32122553
[TBL] [Abstract][Full Text] [Related]
13. Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues.
Hernandez S; Rojas F; Laberiano C; Lazcano R; Wistuba I; Parra ER
Front Mol Biosci; 2021; 8():667067. PubMed ID: 33996912
[TBL] [Abstract][Full Text] [Related]
14. Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis.
Eng J; Thibault G; Luoh SW; Gray JW; Chang YH; Chin K
Methods Mol Biol; 2020; 2055():521-562. PubMed ID: 31502168
[TBL] [Abstract][Full Text] [Related]
15. Multiplex Immunofluorescence and the Digital Image Analysis Workflow for Evaluation of the Tumor Immune Environment in Translational Research.
Rojas F; Hernandez S; Lazcano R; Laberiano-Fernandez C; Parra ER
Front Oncol; 2022; 12():889886. PubMed ID: 35832550
[TBL] [Abstract][Full Text] [Related]
16. Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma.
Lee CW; Ren YJ; Marella M; Wang M; Hartke J; Couto SS
J Immunol Methods; 2020 Mar; 478():112714. PubMed ID: 31783023
[TBL] [Abstract][Full Text] [Related]
17. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
Kwon MJ
Arch Pharm Res; 2019 Nov; 42(11):947-961. PubMed ID: 31707598
[TBL] [Abstract][Full Text] [Related]
18. Refining patient selection for breast cancer immunotherapy: beyond PD-L1.
Kossai M; Radosevic-Robin N; Penault-Llorca F
ESMO Open; 2021 Oct; 6(5):100257. PubMed ID: 34487970
[TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Immune Microenvironment by Multiplex Immunohistochemistry Staining in Different Oral Diseases and Oral Squamous Cell Carcinoma.
Qiao B; Huang J; Mei Z; Lam AK; Zhao J; Ying L
Front Oncol; 2020; 10():555757. PubMed ID: 33364188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
